|
|
J Lillienau, C D Schteingart, A F Hofmann
J Clin Invest. 1992;
89(2):420
doi:10.1172/JCI115601
Abstract |
Full text
| PDF

T
he properties of cholylsarcosine (the synthetic N-acyl conjugate of cholic acid with sarcosine [N-methylglycine]) were examined to determine its suitability as a bile acid replacement agent for conditions of bile acid deficiency in the small intestine, which causes fat malabsorption. Previous studies in rodents had shown that the compound was well transported by the liver and ileum and underwent neither deconjugation nor dehydroxylation during enterohepatic cycling. By 1H-nuclear magnetic resonance, cholylsarcosine was found to exist in dilute aqueous solution as an almost equimolar mixture of two geometric isomers--cis and trans (around the amide bond)--in contrast to cholylglycine, which was present entirely in the trans form. The critical micellization concentration was 11 mmol/liter, similar to that of cholylglycine (10 mmol/liter). By nonaqueous titrimetry, the pKa' of cholylsarcosine was 3.7, only slightly lower than that of cholylglycine (3.9). Cholylsarcosine was poorly soluble below pH 3.7, but highly soluble above pH 4. In vitro, cholylsarcosine behaved as cholylglycine with respect to promoting lipolysis by lipase/colipase. There was little difference between cholylsarcosine and cholylglycine in their solubilization of an equimolar mixture of oleic acid, oleate, and monoolein (designed to simulate digestive products of triglyceride) or in their solubilization of monooleyl-glycerol alone. When a [3H]triolein emulsion with either cholylsarcosine or cholyltaurine was infused intraduodenally in biliary fistula rats, recovery of 3H in lymph was 52 +/- 10% (mean +/- SD) for cholylsarcosine and 52 +/- 11% for cholyltaurine. When perfused into the colon of the anesthetized rabbit, cholylsarcosine (5 mmol/liter) did not influence water absorption or permeability to erythritol, in contrast to chenodeoxycholate, which induced vigorous water secretion and caused erythritol loss. We conclude that cholylsarcosine possesses the physicochemical and physiological properties required for a suitable bile acid replacement in deficiency states.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(11)
| Title and authors |
Publication |
Year |
In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules
Johannes Parmentier, Felix J. Hartmann, Gert Fricker
|
European Journal of Pharmaceutics and Biopharmaceutics
|
2010 |
Bile acids: Trying to understand their chemistry and biology with the hope of helping patients
Alan F. Hofmann
|
Hepatology
|
2009 |
Bile acid malabsorption
Henrik Westergaard
|
Curr Treat Options Gastro
|
2008 |
Intestinal Failure and Rehabilitation
Darwin Conwell, Tyler Stevens
|
Intestinal Failure and Rehabilitation
|
2004 |
Effect of excipients on the stability and transport of recombinant human epidermal growth factor (rhEGF) across CACO-2 cell monolayers
In-Wha Kim, Ho-Jung Yoo, Im-Sook Song, Youn-Bok Chung, Dong-Cheul Moon, Suk-Jae Chung, Chang-Koo Shim
|
Arch. Pharm. Res.
|
2003 |
In vivo absorption of medium-chain fatty acids by the rat colon exceeds that of short-chain fatty acids
Jimmy R. Jørgensen, Mark D. Fitch, Per B. Mortensen, Sharon E. Fleming
|
Gastroenterology
|
2001 |
Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine
S Michael
|
European Journal of Pharmaceutical Sciences
|
2000 |
Management of the Patient With Short Bowel Syndrome
Linda M. Lord, Robert Schaffner, Arthur J. DeCross, Harry C. Sax
|
AACN Clinical Issues: Advanced Practice in Acute & Critical Care
|
2000 |
Conjugated bile acid replacement therapy for short-bowel syndrome
Christine Gruy-Kapral, Katherine H. Little, John S. Fordtran, Tom L. Meziere, Lee R. Hagey, Alan F. Hofmann
|
Gastroenterology
|
1999 |
N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: Effects of acute feeding in the rat
Mario Angelico, Andrea Mangiameli, Alessandra Nistri, Leonardo Baiocchi, Mara Sofia, Mario Maina, Mario Di Martino, Adriano Blasi
|
Hepatology
|
1995 |
|